Genentech, Inc.

Genentech, Inc.

Genentech, Inc.

Overview
Date Founded

1986

Headquarters

1 DNA Way,Mailstop 258A,South San Francisco, CA 94080

Type of Company

Private

Employees (Worldwide)

11.2K

Industries

Pharmaceuticals
Industrial Machinery & Manufacturing
Biotechnology

Company Description

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer, Kenneth B. Lee and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

Contact Data
Trying to get in touch with decision makers at Genentech, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive Officer

Senior Vice President & General Counsel

Director, Chief Medical Officer & Executive Vice President

Chief Financial Officer & Head of Pharma Finance North America

Chief Executive Officer, Roche Pharmaceuticals

Senior Vice President & Head-Pharmaceutical Technical Operations

Head, Research & Early Development

Global Head, Pharmaceutical Technical Development

Head, Research & Early Development

Senior Vice President of Human Resources & Regional Human Resources Head, North America

Board of Directors

Chief Executive Officer at Roche Holding AG

Director, Chief Medical Officer & Executive Vice President at Genentech, Inc.

Head, Research & Early Development at Genentech, Inc.

Venture Partner at LSP Management Group BV

Treasurer & Director at Fondation Auxiliaire du Conservatoire botanique de la Ville de

Chief Financial & Information Technology Officer at Roche Holding AG

Chief Executive Officer at Genentech, Inc.

Chief Executive Officer, Roche Pharmaceuticals at Genentech, Inc.

President at The Rockefeller University

Senior Vice President & General Counsel at Genentech, Inc.

Paths to Genentech, Inc.
Potential Connections via
Relationship Science
You
Genentech, Inc.
Recent Transactions
Details Hidden

Genentech, Inc., Roche Holding AG purchase Jecure Therapeutics, Inc. from Versant Venture Management LLC

Details Hidden

Roche Holding AG, Genentech, Inc. purchase Seragon Pharmaceuticals, Inc. from Aisling Capital, venBio Partners LLC, The Column Group LLC, OrbiMed Advisors Private Equity, Topspin Management LLC

Details Hidden

Genentech, Inc., Roche Holding AG purchase RQx Pharmaceuticals, Inc. from Correlation Management LLC, Avalon Ventures Management LLC

Transaction Advisors
Legal Advisor

Advised onRoche Holding AG purchases Genentech, Inc.

Investment Advisor

Advised onRoche Holding AG purchases Genentech, Inc.

Selling Group Member

Advised onGenentech, Inc. issued USD Common Stock

Legal Advisor

Advised onRoche Holding AG purchases Genentech, Inc.

Legal Advisor

Advised onGenentech, Inc., Roche Holding AG purchase Seragon Pharmaceuticals, Inc. from Topspin Management LLC, Aisling Capital, OrbiMed Advisors Private Equity, The Column Group LLC, venBio Partners LLC

Global Co-Chairman, Mergers & Acquisitions Group

Advised onRoche Holding AG purchases Genentech, Inc.

Advisors & Consultants
Legal Advisor

Managing Partner at Hogan & Lovells LLP

Legal Advisor

Partner at Cooley LLP

Legal Advisor

Partner at Wilson Sonsini Goodrich & Rosati PC

Clients

COORDINATION OF ADULT ONCOLOGY SERVICES to patients of Dana-Farber and participating hospitals and assisting in coordinating mission related programs and research.

Key Stats and Financials As of 2020
Market Capitalization
Total Enterprise Value
Earnings Per Share
Revenue
$3.74B
Non-Profit Donations & Grants
$100K - $250K
2020
Political Donations
$250
2014
$1,000
2014
$500
2014
Investments
Details Hidden

Cellective Therapeutics, Inc. provides biopharmaceuticals products. It develops monoclonal antibodies for the treatment of oncology and autoimmune diseases. Cellective Therapeutics products include monoclonal antibodies that target the B-cell antigens CD19, CD20 and CD22 are in preclinical stage programs. It was founded by Thomas F. Tedder and Alter E. Geller in May, 2003 and is headquartered in Durham, NC

Details Hidden

Horizon Discovery Group Plc is a cell engineering company, which engages in the design and engineering of genetically-modified cells. The firm operates through the following business segments: Products, Services, and Leveraged Research & Development. The Products segment sells cell lines and other products. The Services segment offers cell line manufacturing services. The Leveraged Research & Development segment business unit is operated on a portfolio basis. It serves pharmaceutical, biotechnology, and diagnostic companies. The company was founded by Christopher John Torrance, Adam John Collier, and Alberto Bardelli in July 2005 and is headquartered in Cambridge, the United Kingdom.

Investors
Details Hidden

Professional at Genentech, Inc.

Awards & Honors
Rank #6
2017
Fortune Magazine - The 100 Best Companies to Work For
Sponsored by Fortune Magazine
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Genentech, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Genentech, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Genentech, Inc..